INTERNATIONAL PATENT: EVOLVEIMMUNE THERAPEUTICS, INC., DHINDWAL, SONALI FILES APPLICATION FOR "BISPECIFIC ANTIBODY FUSION MOLECULES TARGETING B7-H4 AND CD3 AND METHODS OF USE THEREOF"

GENEVA, March 25 -- EVOLVEIMMUNE THERAPEUTICS, INC. (23 Business Park DriveBranford, Connecticut 06405), DHINDWAL, Sonali (93 Florence RoadUnit 2ABranford, Connecticut 06405) filed a patent application (PCT/US2024/045986) for "BISPECIFIC ANTIBODY FUSION MOLECULES TARGETING B7-H4 AND CD3 AND METHODS OF USE THEREOF" on Sep 10, 2024. With publication no. WO/2025/059037, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SARKAR, Mohosin (19 Timber LaneWoodbridge, Connecticut 06525), MYERS, Jeremy S. (435 Treat LaneOrange, Connec...